Evidence map›Paper›PMID 33567603›Full record

ArticleCancers2021

Subcellular Localization of uc.8+ as a Prognostic Biomarker in Bladder Cancer Tissue.

Sara Terreri, Sara Mancinelli, Matteo Ferro, Maria Concetta Vitale, Sisto Perdonà, Luigi Castaldo, Vincenzo Gigantino, Vincenzo Mercadante, Rossella De Cecio, Gabriella Aquino and 12 more

Abstract read
In one paragraph

Article in Cancers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Identification of atrial-enriched lncRNA Walras linked to cardiomyocyte cytoarchitecture and atrial fibrillation.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Sara TerreriInstitute of Genetics and Biophysics "A. Buzzati Traverso", National Research Council (CNR), 80131 Naples, Italy.ORCID 0000-0002-5791-6306
Sara MancinelliInstitute of Genetics and Biophysics "A. Buzzati Traverso", National Research Council (CNR), 80131 Naples, Italy.ORCID 0000-0002-6290-5425
Matteo FerroDivision of Urology, European Institute of Oncology IRCCS, 20141 Milan, Italy.ORCID 0000-0002-9250-7858
Maria Concetta VitaleDepartment of Science and Technology, University of Naples Parthenope, 80143 Naples, Italy.ORCID 0000-0002-5538-9952
Sisto PerdonàUro-Gynecological Department, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione "G. Pascale"-IRCCS, 80131 Naples, Italy.
Luigi CastaldoUro-Gynecological Department, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione "G. Pascale"-IRCCS, 80131 Naples, Italy.
Vincenzo GigantinoPathology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione "G. Pascale"-IRCCS, 80131 Naples, Italy.
Vincenzo MercadanteInstitute of Genetics and Biophysics "A. Buzzati Traverso", National Research Council (CNR), 80131 Naples, Italy.
Rossella De CecioPathology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione "G. Pascale"-IRCCS, 80131 Naples, Italy.
Gabriella AquinoPathology Unit, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione "G. Pascale"-IRCCS, 80131 Naples, Italy.
Marco MontellaSection of Pathology, Department of Physical and Mental Health and Preventive Medicine, Università degli studi della Campania "Luigi Vanvitelli", 80131 Naples, Italy.
Claudia AngeliniInstitute for Applied Mathematics "Mauro Picone", National Research Council (CNR), 80131 Naples, Italy.ORCID 0000-0001-8350-8464
Eugenio Del PreteInstitute for Applied Mathematics "Mauro Picone", National Research Council (CNR), 80131 Naples, Italy.
Marianna AprileInstitute of Genetics and Biophysics "A. Buzzati Traverso", National Research Council (CNR), 80131 Naples, Italy.ORCID 0000-0001-7055-4306
Angelo CiaramellaDepartment of Science and Technology, University of Naples Parthenope, 80143 Naples, Italy.ORCID 0000-0001-5592-7995
Giovanna L LiguoriInstitute of Genetics and Biophysics "A. Buzzati Traverso", National Research Council (CNR), 80131 Naples, Italy.ORCID 0000-0002-7239-3224
Valerio CostaInstitute of Genetics and Biophysics "A. Buzzati Traverso", National Research Council (CNR), 80131 Naples, Italy.ORCID 0000-0002-7294-6933
George A CalinTranslational Molecular Pathology Department and Leukemia Department, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Evelina La CivitaDepartment of Translational Medical Sciences, University of Naples "Federico II", 80131 Naples, Italy.
Daniela TerraccianoDepartment of Translational Medical Sciences, University of Naples "Federico II", 80131 Naples, Italy.ORCID 0000-0003-4296-429X
Ferdinando FebbraioInstitute of Biochemistry and Cell Biology, National Research Council (CNR), 80131 Naples, Italy.ORCID 0000-0002-3653-9847
Amelia CimminoInstitute of Genetics and Biophysics "A. Buzzati Traverso", National Research Council (CNR), 80131 Naples, Italy.ORCID 0000-0002-0004-9299

Funding

Horizon 2020 Framework Programme 801338.My First AIRC Grant 23453SATIN-POR CAMPANIA FESR 2014/2020
6 · The paper itself

Abstract

Non-coding RNA transcripts originating from Ultraconserved Regions (UCRs) have tissue-specific expression and play relevant roles in the pathophysiology of multiple cancer types. Among them, we recently identified and characterized the ultra-conserved-transcript-8+ (uc.8+), whose levels correlate with grading and staging of bladder cancer. Here, to validate uc.8+ as a potential biomarker in bladder cancer, we assessed its expression and subcellular localization by using tissue microarray on 73 human bladder cancer specimens. We quantified uc.8+ by in-situ hybridization and correlated its expression levels with clinical characteristics and patient survival. The analysis of subcellular localization indicated the simultaneous presence of uc.8+ in the cytoplasm and nucleus of cells from the Low-Grade group, whereas a prevalent cytoplasmic localization was observed in samples from the High-Grade group, supporting the hypothesis of uc.8+ nuclear-to-cytoplasmic translocation in most malignant tumor forms. Moreover, analysis of uc.8+ expression and subcellular localization in tumor-surrounding stroma revealed a marked down-regulation of uc.8+ levels compared to the paired (adjacent) tumor region. Finally, deep machine-learning approaches identified nucleotide sequences associated with uc.8+ localization in nucleus and/or cytoplasm, allowing to predict possible RNA binding proteins associated with uc.8+, recognizing also sequences involved in mRNA cytoplasm-translocation. Our model suggests uc.8+ subcellular localization as a potential prognostic biomarker for bladder cancer.

Indexed as

bladder cancerlong noncoding RNAprognostic biomarkertranscribed-ultraconserved regionultraconserved region

Identifiers

PMID33567603
PMCPMC7914980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.